Taiwan: Hemp

  |   Attaché Report (GAIN)   |   TW2021-0033

Taiwan does not have a market for hemp products because cannabis is classified as a Class 2 narcotic. All drugs or products that contain tetrahydrocannabinol (THC) over 10ug/g (10ppm) are in the same class of narcotics. Taiwan’s Food and Drug Administration specifies that drugs containing cannabidiol (CBD) are allowed, but there are currently no domestic approved drugs with CBD content and there is no rule or law allowing for the sale of CBD related products and drugs in Taiwan. Therefore, Taiwan currently has very little to no potential for importing hemp or hemp related products.

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.